MECHANISMS OF DIFFERENTIAL SLEEPINESS IN SLEEP APNEA
MECHANISMS OF DIFFERENTIAL SLEEPINESS IN SLEEP APNEA
批准号:
7510339
负责人:
TERRI Elizabeth WEAVER
金额:
$49.87万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AccountingAgeApneaBedsBehaviorBiologicalCardiovascular DiseasesCharacteristicsClassificationClinicalCommunitiesComorbidityContinuous Positive Airway PressureDataDevelopmentDizygotic TwinsElderlyElectroencephalographyEvaluationExcessive Daytime SleepinessExposure toFatty acid glycerol estersFemaleGenderHeritabilityHome environmentHomeostasisHypersomnolenceImpairmentIndividualIndividual DifferencesInterventionLaboratoriesLightMeasuresMental DepressionMethodologyNewly DiagnosedNumbersObesityObstructive Sleep ApneaOutcome StudyPainPatient MonitoringPatientsPharmaceutical PreparationsPolysomnographyPopulationProtocols documentationProxyPurposeRecording of previous eventsRecoveryRecruitment ActivityRegulationRelative RisksReportingResidual stateRisk FactorsScoreSeveritiesSeverity of illnessSleepSleep Apnea SyndromesSleep DeprivationSleep FragmentationsSourceTask PerformancesTestingTimeWakefulnessactigraphybasecytokinedaydiariesexperiencefunctional declineinstrumentmaleneurobehavioralprogramsrespiratoryresponsesleep regulationtraitvigilance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of this proposal is to explore potential operating mechanisms in the differential sleepiness observed in patients with equivalent degrees of obstructive sleep apnea (OSA). Within a given level of disease severity, i.e., number of respiratory disturbances during sleep, inter-individual differences, or differential vulnerability to sleepiness, have been noted in both subjectively measured and objectively measured daytime sleepiness. The reason for this
phenomenon remains unclear. Critical to the management of patients with OSA is the understanding of mechanisms associated with the development of daytime sleepiness. We hypothesize that the variance in daytime sleepiness (EDS)will have a substantial trait component in addition to state-related factors among patients with equivalent levels of OSA severity. To systematically identify sources of EDS variance in sleepy and non-sleepy OSA patients, the
specific aims of this study will determine: 1) state-specific variance related to sleep duration, obesity and fat distribution, specific comorbidities, and use of certain medications; 2) mis-estimation of severity of sleep disordered breathing from night-to-night variability in respiratory disturbances; 3) underlying trait associated with differential vulnerability to the sleepiness-producing effects of OSA. Using actigraphy and diaries to document sleep duration and both objective and subjective evaluations of sleepiness, Protocol A will classify 260 newly diagnosed OSA subjects as sleepy vs. non-sleepy and will document inter-individual differences in sleepiness among patients with similar disease severity caused by sleep history, obesity and fat distribution, specific comorbidities, and use of certain medications. Controlling for the variance identified in Protocol A, Protocol B will determine the degree to which inter-individual
differences in sleepiness in 180 untreated OSA subjects with similar disease severity is a consequence of night-to-night variability in the occurrence of sleep disordered breathing documented by 7 consecutive nights of home sleep studies. Such night-to-night variability would reduce the reliability of single night determinations of apnea severity. Finally, in
Protocol C we will determine if inter-individual differences in sleepiness remain after accounting for the variance explained by the clinical factors identified in Protocol A and the variance explained by mis-estimation of severity of sleep disordered breathing documented in Protocol B. In Protocol C, 60 patients (30 sleepy, 30 non-sleepy) will be matched on initial apnea severity and a set of a priori sleepiness factors will undergo 38 hrs of sleep deprivation in a laboratory to determine the existence of an underlying trait for daytime sleepiness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of CPAP on Functional Outcomes in Milder OSA
-
批准号:6793277
-
项目类别:
-
资助金额:$61.24万
-
财政年份:2003
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
Impact of CPAP on Functional Outcomes in Milder OSA
-
批准号:6600179
-
项目类别:
-
资助金额:$68.16万
-
财政年份:2003
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
Impact of CPAP on Functional Outcomes in Milder OSA
-
批准号:6896584
-
项目类别:
-
资助金额:$60.81万
-
财政年份:2003
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MECHANISMS OF DIFFERENTIAL SLEEPINESS IN SLEEP APNEA
-
批准号:6716888
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2003
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
Impact of CPAP on Functional Outcomes in Milder OSA
-
批准号:7095314
-
项目类别:
-
资助金额:$69.42万
-
财政年份:2003
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
CAUSES OF CPAP NONADHERENCE
-
批准号:6657600
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2002
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
CAUSES OF CPAP NONADHERENCE
-
批准号:6501133
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2001
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
CAUSES OF CPAP NONADHERENCE
-
批准号:6349177
-
项目类别:
-
资助金额:$21.99万
-
财政年份:2000
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
CAUSES OF CPAP NONADHERENCE
-
批准号:6202596
-
项目类别:
-
资助金额:$21.99万
-
财政年份:1999
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MATERNAL OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR IUGR
-
批准号:6274449
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1998
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
CAUSES OF CPAP NONADHERENCE
-
批准号:6110943
-
项目类别:
-
资助金额:$21.99万
-
财政年份:1998
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MATERNAL OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR IUGR
-
批准号:6244400
-
项目类别:
-
资助金额:$2.36万
-
财政年份:1997
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MULTISITE STUDY OF THE FUNCTIONAL OUTCOMES OF CPAP USE
-
批准号:2685437
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1996
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MULTISITE STUDY OF THE FUNCTIONAL OUTCOMES OF CPAP USE
-
批准号:2392757
-
项目类别:
-
资助金额:$11.92万
-
财政年份:1996
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MULTISITE STUDY OF THE FUNCTIONAL OUTCOMES OF CPAP USE
-
批准号:2232157
-
项目类别:
-
资助金额:$12.1万
-
财政年份:1996
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MULTISITE STUDY OF THE FUNCTIONAL OUTCOMES OF CPAP USE
-
批准号:2901204
-
项目类别:
-
资助金额:$12.35万
-
财政年份:1996
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
VARIABLES RELATED TO FUNCTIONAL STATUS IN COPD
-
批准号:3026997
-
项目类别:
-
资助金额:$0.45万
-
财政年份:1990
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
VARIABLES RELATED TO FUNCTIONAL STATUS IN COPD
-
批准号:3026996
-
项目类别:
-
资助金额:$1.25万
-
财政年份:1989
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
VARIABLES RELATED TO FUNCTIONAL STATUS IN COPD
-
批准号:3026995
-
项目类别:
-
资助金额:$1.06万
-
财政年份:1988
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
MATERNAL OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR IUGR
-
批准号:6113215
-
项目类别:
-
资助金额:$2.66万
-
财政年份:--
-
负责人:TERRI Elizabeth WEAVER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: